Overview of Medicare Part D prescription drug benefit: Potential implications for patients with psychotic disorders

被引:1
|
作者
Rosenberg, Jack A.
机构
[1] Long Isl Univ, Int Drug Informat Ctr, Brooklyn, NY 11201 USA
[2] Long Isl Univ, Arnold & Marie Schwartz Coll Pharm & Hlth Sci, Brooklyn, NY 11201 USA
关键词
costs; economics; healthbenefit programs; laws; pharmacists; prescriptions; psychotherapeutic agents; psychotic disorders;
D O I
10.2146/ajhp060592
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Purpose. Medicare Part D prescription drug benefits are reviewed. Potential implications, for patients with psychotic disorders in relation to Medicare Part D are discussed. Summary. The newly created Medicare Part D provides prescription drug benefits to many individuals formerly without prescription benefits and, possibly, lower-cost benefits to those who previously relied on other benefits., Participating prescription plans use a variety of pharmacy management tools to minimize costs while providing benefit plans that meet Part D requirements for composition and coverage. Patients then have the challenge of choosing a prescription drug plan that will best satisfy their prescriptions needs. Conclusion. The rollout of Part D has not been without problems, and although more Medicare participants are receiving prescription drug benefits at a greater savings,there are concerns that Part D may not provide adequate coverage for all patients or for patients requiring certain types of medications, especially some psychotropic medications. Pharmacists have voiced concerns about the Medicare Part D drug plan in regard to both the degree of coverage it provides to enrollees and the difficulty in administering the benefit.
引用
收藏
页码:S18 / S23
页数:6
相关论文
共 50 条
  • [11] Implementation of the Medicare Part D Prescription Drug Benefit is Associated with Antiretroviral Therapy Interruptions
    Das-Douglas, Moupali
    Riley, Elise D.
    Ragland, Kathleen
    Guzman, David
    Clark, Richard
    Kushel, Margot B.
    Bangsberg, David R.
    AIDS AND BEHAVIOR, 2009, 13 (01) : 1 - 9
  • [12] Low-Income Medicare Beneficiaries and their Experiences with the Part D Prescription Drug Benefit
    Rudolph, Noemi V.
    Montgomery, Melissa A.
    INQUIRY-THE JOURNAL OF HEALTH CARE ORGANIZATION PROVISION AND FINANCING, 2010, 47 (02) : 162 - 172
  • [13] Implementation of the Medicare Part D Prescription Drug Benefit is Associated with Antiretroviral Therapy Interruptions
    Moupali Das-Douglas
    Elise D. Riley
    Kathleen Ragland
    David Guzman
    Richard Clark
    Margot B. Kushel
    David R. Bangsberg
    AIDS and Behavior, 2009, 13
  • [14] Medicare's New Part D Prescription Drug Benefit: A Major Work in Progress
    Bailes, Joseph
    JOURNAL OF ONCOLOGY PRACTICE, 2005, 1 (04) : 162 - 166
  • [15] The Medicare Prescription Drug Benefit
    Baier, Fay
    AMERICAN JOURNAL OF NURSING, 2006, 106 (06) : 66 - +
  • [16] Who Thinks That Part D Is Too Complicated? Survey Results on the Medicare Prescription Drug Benefit
    Cummings, Janet R.
    Rice, Thomas
    Hanoch, Yaniv
    MEDICAL CARE RESEARCH AND REVIEW, 2009, 66 (01) : 97 - 115
  • [17] Who Enrolls in the Medicare Part D Prescription Drug Benefit Program? Medication Use Among Patients With Heart Failure
    Eapen, Zubin J.
    Hammill, Bradley G.
    Setoguchi, Soko
    Schulman, Kevin A.
    Peterson, Eric D.
    Hernandez, Adrian F.
    Curtis, Lesley H.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2013, 2 (05):
  • [18] A drug benefit: The necessary prescription for medicare
    Rother, J
    HEALTH AFFAIRS, 1999, 18 (04) : 20 - 22
  • [19] The costs of a Medicare prescription drug benefit
    Christensen, S
    Wagner, J
    HEALTH AFFAIRS, 2000, 19 (02) : 212 - 218
  • [20] Implementing the medicare prescription drug benefit
    Crystal, S
    GERONTOLOGIST, 2004, 44 : 382 - 382